Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Pediatric Infectious Disease Journal|December 20, 2012
Adherence and viral suppression among infants and young children initiating protease inhibitor-based antiretroviral therapyChloe A Teasdale, Elaine J Abrams, Ashraf Coovadia, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 3, 2011
Lipid profiles in young HIV-infected children initiating and changing antiretroviral therapyRenate Strehlau, Ashraf Coovadia, Elaine J Abrams, et al.
Archives of Disease in Childhood|December 11, 2012
Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapyStephen Arpadi, Stephanie Shiau, Renate Strehlau, et al.
The Journal of Pediatrics|January 15, 2013
Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virusStephanie Shiau, Stephen Arpadi, Renate Strehlau, et al.
The Pediatric Infectious Disease Journal|June 3, 2011
Absence seizures associated with efavirenz initiationRenate Strehlau, Leigh Martens, Ashraf Coovadia, et al.
BMC Pediatrics|February 14, 2014
Sex differences in responses to antiretroviral treatment in South African HIV-infected children on ritonavir-boosted lopinavir- and nevirapine-based treatmentStephanie Shiau, Louise Kuhn, Renate Strehlau, et al.
JAMA|November 4, 2015
Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: A Randomized Clinical TrialAshraf Coovadia, Elaine J Abrams, Renate Strehlau, et al.
Antiviral Therapy|February 13, 2014
Plasma lopinavir concentrations predict virological failure in a cohort of South African children initiating a protease-inhibitor-based regimenRetsilisitsoe R Moholisa, Michael Schomaker, Louise Kuhn, et al.
JAMA|September 9, 2010
Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trialAshraf Coovadia, Elaine J Abrams, Renate Stehlau, et al.
The Lancet. Infectious Diseases|March 20, 2012
Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trialLouise Kuhn, Ashraf Coovadia, Renate Strehlau, et al.
Pageof 1